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Background and purpose   Since the introduction of total hip 
arthroplasty (THA) in Sweden, both components have most com-
monly been cemented. A decade ago the frequency of uncemented 
fixation started to increase, and this change in practice has con-
tinued.  We  therefore  analyzed  implant  survival  of  cemented 
and uncemented THA, and whether the modes of failure differ 
between the two methods of fixation.
Patients and methods   All patients registered in the Swedish 
Hip Arthroplasty Register between 1992 and 2007 who received 
either totally cemented or totally uncemented THA were identi-
fied (n = 170,413). Kaplan-Meier survival analysis with revision 
of any component, and for any reason, as the endpoints was per-
formed. Cox regression models were used to calculate risk ratios 
(RRs) for revision for various reasons, adjusted for sex, age, and 
primary diagnosis.
Results   Revision-free 10-year survival of uncemented THA 
was lower than that of cemented THA (85% vs. 94%, p < 0.001). 
No age or diagnosis groups benefited from the use of uncemented 
fixation. Cox regression analysis confirmed that uncemented THA 
had a higher risk of revision for any reason (RR = 1.5, 95% CI: 
1.4–1.6) and for aseptic loosening (RR = 1.5, CI: 1.3–1.6). Unce-
mented cup components had a higher risk of cup revision due to 
aseptic loosening (RR = 1.8, CI: 1.6–2.0), whereas uncemented 
stem components had a lower risk of stem revision due to asep-
tic loosening (RR = 0.4, CI: 0.3–0.5) when compared to cemented 
components. Uncemented stems were more frequently revised due 
to periprosthetic fracture during the first 2 postoperative years 
than cemented stems (RR = 8, CI: 5–14). The 5 most common 
uncemented cups had no increased risk of revision for any reason 
when compared with the 5 most commonly used cemented cups 
(RR = 0.9, CI: 0.6–1.1). There was no significant difference in 
the risk of revision due to infection between cemented and unce-
mented THA.
Interpretation   Survival of uncemented THA is inferior to that 
of cemented THA, and this appears to be mainly related to poorer 
performance  of  uncemented  cups.  Uncemented  stems  perform 
better than cemented stems; however, unrecognized intraopera-
tive femoral fractures may be an important reason for early fail-
ure of uncemented stems. The risk of revision of the most common 
uncemented cup designs is similar to that of cemented cups, indi-
cating that some of the problems with uncemented cup fixation 
may have been solved. 

 
During the 1970s, after about one decade of successfully per-
formed cemented total hip arthroplasties (THAs), uncemented 
implants  were  introduced  in  increasing  numbers.  Different 
principles of fixation such as screw rings, press-fit with or 
without additional screws, and various new materials were 
used. With time, it became evident that these materials should 
have good biocompatibility and a specific surface structure 
to achieve secondary fixation to the bone, in order to avoid 
later loosening. Many implant designs not fulfilling these cri-
teria turned out to be failures, unfortunately often in a large 
number of patients. When the problem of fixation seemed to 
be solved, wear and osteolysis reappeared also with unce-
mented cups and turned out to be even worse than observed 
for the cemented designs. Even today, the focus is on the 
articulating surfaces and materials with the hope that recent 
technology will solve these problems. Numerous uncemented 
implants with different appearances have indeed shown excel-
lent results in small or medium-sized cohorts (Badhe et al. 
2002, Gabbar et al. 2008, Reigstad et al. 2008, Aldinger et al. 
2009, Gwynne-Jones et al. 2009), in contrast to older designs 
with unacceptable failure rates (Puolakka et al. 1999, Thanner 
et al. 1999, Lai et al. 2002).
In Sweden, the Swedish Hip Arthroplasty Register (SHAR) 
has well-documented low revision rates after cemented THA 
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swiftly  introducing  uncemented  THA—which  became  fre-
quently used in many other European countries and in North 
America. Although the use of uncemented THA has increased 
steadily and slowly for many years in Sweden, the proportion 
of uncemented THA relative to cemented THA is still low by 
international standards (Swedish Hip Arthroplasty Register, 
Annual Report 2007). Cemented THA remains the gold stan-
dard for older patients (> 65 yrs) and for almost all patients 
with  cervical  neck  fractures,  whereas  uncemented THA  is 
more commonly used in younger patients.
Our objective was to compare the outcome of uncemented 
and cemented THA in the SHAR. Specifically, we intended 
to investigate whether certain age groups or disease groups 
might benefit more than others from the use of uncemented 
THA, and whether modes of failure differ between the two 
fixation principles.
Patients and methods
Sources of data
Data were extracted from the Swedish Hip Arthroplasty Reg-
ister (SHAR). Each patient receiving a primary or secondary 
THA is registered and reported by the operating unit using a 
personal identification number. This number is linked to rel-
evant information such as change of address, date of emigra-
tion, or the date of death. The Swedish Hip Arthroplasty Reg-
ister has been validated repeatedly (Söderman 2000, Swedish 
Hip Arthroplasty Register, Annual Report 2007). Since 1992, 
detailed information on demographics and implant specifica-
tions have been linked to the personal identification number, 
which enables more comprehensive and reliable studies of 
individual implant designs, as in this study. All units perform-
ing THA in Sweden report to the register and completeness 
on an individual basis is 98% for primary THA and 94% for 
revision THA.
Study population
We  identified  all  primary  THAs  registered  in  the  SHAR 
between 1992 and 2007 that were operated with either totally 
cemented  or  totally  uncemented  fixation.  Hybrid,  inverse 
hybrid, and resurfacing arthroplasties were excluded. This left 
a study population of 145,339 patients with 170,413 THAs.
Statistics
Follow-up started on the day of primary THA and ended on 
the day of revision, death, emigration, or December 31, 2007, 
whichever came first. Revision was defined as exchange or 
removal of any part of the cup or stem, or the entire implant.
Kaplan-Meier survival analyses were performed with the 
type of fixation as the independent factor, and revision of any 
component  and  for  any  reason  as  primary  endpoints.  Fur-
ther analyses were performed after stratification according to 
age group (< 50, 50–59, 60–75, > 75 years), or after strati-
fication according to diagnosis group (primary osteoarthritis 
(OA), inflammatory hip disease (e.g. rheumatoid arthritis, M. 
Bechterew),  femoral  neck  fracture,  childhood  hip  disease, 
idiopathic  femoral  head  necrosis,  secondary  posttraumatic 
OA,  tumor).  The  log-rank  test  (Mantel-Cox)  was  used  to 
investigate whether there was a significant difference between 
groups, and p < 0.05 was chosen as the predetermined level of 
significance.
In order to adjust for possible confounding factors, a Cox 
proportional hazards model was used to analyze the relative 
risk (RR) of revision with 95% confidence intervals (CIs). 
Endpoints were revision of any component (1) for any reason, 
(2) due to infection, (3) due to aseptic loosening, or (4) due 
to periprosthetic fracture. We hypothesized that the reasons 
for revision might differ between uncemented and cemented 
THA during the early phase after the index procedure; thus, 
we performed a separate analysis with revision for any reason 
within 2 years of the index procedure, or with revision due to 
periprosthetic fracture within 2 years of the index procedure 
as the endpoint. In further analyses, the endpoint was revision 
of either cup or stem for the reasons described above. In a 
separate set of analyses, the 5 most commonly used implants 
in each group were compared with each other: the 5 most 
common cemented cups (Lubinus, Charnley, Exeter Duration, 
Charnley Elite, and Reflection) with the 5 most common unce-
mented cups (Trilogy HA, CLS Spotorno, Trilogy, Trident HA, 
and Allofit), and the 5 most common cemented stems (Lubi-
nus SP2, Exeter polished, Charnley, Spectron EF Primary, and 
Scan Hip Collar) with the 5 most common uncemented stems 
(CLS, Bi-Metric HA, ABG, Omnifit, and Wagner Cone). The 
covariates type of fixation (cemented or uncemented), sex, age 
(stratified into the 4 age groups described above), and primary 
diagnosis before THA surgery (see above) were entered into 
the model. An initial analysis was performed where all covari-
ates mentioned above were entered as singular variables and 
a crude risk ratio was calculated for each variable. Thereafter, 
all covariates mentioned above were entered in the regression 
model and risk ratios were mutually adjusted for all covari-
ates.
The assumption of proportional hazards was investigated 
and verified by hazard-function plots that never crossed or 
approximated each other in any analysis, and by log-minus-
log plots that ran strictly parallel in all analyses. It has been 
pointed  out  that  the  inclusion  of  both THAs  in  bilaterally 
operated patients can create dependency problems (Ranstam 
2002), and we therefore investigated whether our Cox regres-
sion model was robust against this potential violation. Separate 
analyses were done either after including all THAs (170,413 
THAs in 145,339 individuals) or after excluding the second 
side in bilaterally operated patients (leaving 145,339 THAs in 
145,339 individuals). The calculated adjusted risk ratios were 
not statistically significantly affected by the inclusion of both 
THAs in bilaterally operated patients (data not shown), which 
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2004, Thillemann et al. 2008). Statistical analyses were per-
formed using SPSS (version 16.0), except for the calculation 
of life tables, which was carried out with SAS (version 9.2).
Results
Characteristics of the study population
There were more females than males in the study population, 
and primary osteoarthritis was the most common preoperative 
diagnosis. Most patients were in the 60–75-year age group 
(Table  1).  Cemented  components  were  chosen  in  161,460 
procedures;  8,953  were  totally  uncemented.  The  10  most 
commonly used cup and stem implants in the two groups are 
described in Table 2. By 2007, 6,636 (3.9%) of all 170,413 
arthroplasties had been revised, mostly due to aseptic loosen-
ing (2.3%), dislocation (0.7%), or deep infection (0.5%). The 
mean observation time was 5.9 years (SD 4) for the group of 
cemented THAs and 4.9 years (SD 4.5) for the group of unce-
mented THAs.
Revision risk—all cemented vs. all uncemented
Kaplan-Meier  survival  analysis  showed  that  revision-free 
component survival at 10 years was lower for uncemented 
Table 1. Patient demographics 
   n   %
Sex  
  Male   56,532   39
  Female   88,805   61
Age (years) 
  0–49   5,182   4
  50–59   16,182   11
  60–75   74,950   52
  > 75   49,025   34
Primary diagnosis 
  Primary OA   110,438   76
  Inflammatory disease   5,397   4
  Fracture   18,832   13
  Pediatric hip disease   2,073   1
  Idiopathic femoral head necrosis   4,430   3
  Secondary posttraumatic OA   371   0.3
  Others      1
Table 2. The 10 most common implants
   n   %
A) The 10 most common cemented cups
  Lubinus   62,044   38
   Charnley   28,386   18
   Exeter Duration   11,938   7
   Charnley Elite   11,351   7
   Reflection   8,351   5
  Exeter Plast   6,668   4
  FAL   4,513   3
   Biomet Müller   4,099   3
   Scan Hip Cup   3,937   2
   OPTICUP   3,779   2
  Other      2
B) The 10 most common cemented stems
  Lubinus SP II   69,991   43
  Exeter Polished   33,347   21
  Charnley   23,649   15
  Spectron EF Primary   8,093   5
  Scan Hip Collar   2,989   2
  Charnley Elite Plus   2,716   2
  Scan Hip II Collar   2,229   1
  Müller Straight Stem   2,165   1
  Bi-Metric cemented   1,529   1
  MS30 Polished   1,509   1
  Other      8
C) The 10 most common uncemented cups
  Trilogy HA   1,856   21
  CLS Spotorno   1,026   12
  Trilogy   868   10
  Trident HA   770   9
  Allofit   725   8
  ABG II HA   433   5
  Romanus   405   5
  Romanus HA   351   4
  Omnifit   325   4
  ABG HA   287   3
  Other      21
D) The 10 most common uncemented stems
  CLS Spotorno   3,572   40
  Bi-Metric HA uncemented   729   8
  ABG uncemented   492   6
  Omnifit   482   5
  Wagner Cone Prosthesis   370   4
  Accolade   369   4
  Bi-Metric uncemented   334   4
  ABG II HA   313   4
  Bi-Metric lateral   287   3
  Versys   263   3
  Other      20
Kaplan-Meier analysis of survival of cemented and uncemented THA. 
Revision-free  survival  was  significantly  lower  for  uncemented THA 
than for cemented THA with revision of any component for any reason 
as endpoint. Bold lines: survival: thin lines: upper and lower limits of 
95% confidence intervals. 10-year-survival: 85% (CI: 84–87) for unce-
mented THA vs. 94% (CI: 93.8–94.2) for cemented THA (p < 0.05, 
log-rank test). 15-year-survival: 70% (CI: 67–73; 245 THAs at risk) for 
uncemented THA vs. 88% (CI: 88–89; 3,147 THAs at risk) for cemented 
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THA than for cemented THA when revision of any component 
and for any reason was the endpoint (85% vs. 94%, p < 0.001 
(Figure). At 15 years, survival dropped to 70% (CI: 67–73) 
in the group of uncemented THAs and to 88% (CI: 88–89) in 
the group of cemented THAs. After 15 years, there were 245 
THAs at risk in the group of uncemented THAs whereas 3,147 
THAs were at risk among the cemented THAs.
After stratification of the study population into age groups, 
we found that component survival with revision for any reason 
as the endpoint was lower after uncemented THA in all but the 
oldest age group (p < 0.05 for the strata < 50, 50–59, and 60–
75 years). Stratification of the study population into groups of 
diagnoses showed that uncemented THA had lower survival in 
nearly all groups, i.e. primary OA, rheumatoid arthritis, femo-
ral neck fracture, childhood hip disease, idiopathic femoral 
head necrosis, and secondary posttraumatic OA (p < 0.05 in 
these diagnosis groups).
The Cox regression model showed that uncemented THA 
had a higher risk of revision for any reason than cemented 
THA (RR = 1.5, CI: 1.4–1.6) after adjustment for the covari-
ates sex, age, and underlying diagnosis (Table 3 and Table 6). 
Uncemented THA also had a significantly higher risk of revi-
sion due to aseptic loosening (RR = 1.5, CI: 1.3–1.6) (Table 
4 and Table 6). In contrast, uncemented THA did not have a 
higher risk of revision due to infection than cemented THA 
(RR = 0.9, CI: 0.6–1.3) (Table 5 and Table 6).
Revision risk of cup and stem analyzed separately
Uncemented cups had a significantly higher risk of cup revi-
sion due to aseptic loosening than cemented cups (RR = 1.8, 
CI: 1.6–2.0) after adjustment for sex, age, and diagnosis (Table 
6). This difference also persisted after exclusion of revisions 
where only liner exchanges had been performed (RR = 1.5, 
CI: 1.4–1.7).
Table 3. Cox regression model with relative risk (RR) of revision for 
any reason.The covariates type of fixation, sex, age, and underlying 
diagnosis were mutually adjusted for each other. Revision means 
revision of either cup or stem, or both
   Adjusted RR   CI   p-value
    
Type of fixation    
  Cemented a   1   
  Uncemented   1.5   (1.4 –1.6)   < 0.001  
Sex    
  Male a   1   
  Female   0.7   (0.6 –0.7)   < 0.001   
Age    
  < 50 a    1        
  50–59   0.8   (0.7 –0.9)   < 0.001
  60–75   0.5   (0.5 –0.6)   < 0.001
  > 75   0.4   (0.4 –0.4)   < 0.001
Diagnosis    
  Primary OA a    1          
  RA   1.2   (1.1 –1.4)   < 0.001
  Fracture   1.9   (1.7 –2.0)   < 0.001
  Pediatric   1.6   (1.4 –1.8)   < 0.001
  Osteonecrosis   1.5   (1.3 –1.7)   < 0.001
  Posttraumatic OA   2.1   (1.6 –2.8)   < 0.001
  Tumor   2.3   (1.5 –3.5)   < 0.001
  Other secondary arthrosis   1.0   (0.7 –1.3)   0.7
 
a Reference group that other categories are compared to
Table 4. Cox regression model with relative risk (RR) of revision due 
to aseptic loosening. The covariates type of fixation, sex, age, and 
underlying diagnosis were mutually adjusted for each other. Revi-
sion means revision of either cup or stem, or both
     Adjusted  RR   CI   p-value
    
Type of fixation    
  Cemented a   1   
  Uncemented   1.5   (1.3 –1.6)   < 0.001
Sex    
  Male a   1   
  Female   0.7   0.6 –0.7)   < 0.001
Age    
  < 50 a   1   
  50–59  0.7   (0.6 –0.8)   < 0.001
  60–75  0.4   (0.4 –0.5)   < 0.001
  > 75   0.2   (0.2 –0.2)   < 0.001
Diagnosis    
  Primary OA a   1   
  RA   1.1   (1.0 –1.2)   0.2
  Fracture   1.2   (1.1 –1.4)   0.02
  Pediatric   1.5   (1.3 –1.8)   < 0.001
  Osteonecrosis   1.3   (1.1 –1.5)   0.01
  Posttraumatic OA   1.5   (1.0 –2.2)   0.05
  Tumor   1.4   (0.5 –3.7)   0.5
  Other secondary arthrosis   0.7   (0.4 –1.0)   0.03
 
a Reference group that other categories are compared to
Table 5. Cox regression model with relative risk (RR) of revision due 
to infection. The covariates type of fixation, sex, age, and under-
lying  diagnosis  were  mutually  adjusted  for  each  other.  Revision 
means revision of either cup or stem, or both
   Adjusted RR   CI   p-value
    
Type of fixation    
  Cemented a   1   
  Uncemented   0.9   (0.6 –1.3)   0.5
Sex    
  Male a   1   
  Female   0.5   (0.4 –0.5)   < 0.001
Age    
  < 50 a  1   
  50–59   0.8   (0.6 –1.2)   0.4
  60–75   0.7   (0.5 –1.1)   0.1
  > 75   0.7   (0.5 –1.0)   0.07
Diagnosis    
  Primary OA a   1   
  RA   1.4   (1.0 –1.9)   0.04
  Fracture   1.8   (1.4 –2.2)   < 0.001
  Pediatric   1.2   (0.7 –2.0)   0.6
  Osteonecrosis   1.4   (0.9 –2.0)   0.1
  Posttraumatic OA   0.5   (0.1 –3.6)   0.5
  Tumor   1.7   (0.5 –5.3)   0.4
  Other secondary arthrosis   1.1   (0.5 –2.5)   0.8
 
a Reference group that other categories are compared to.38  Acta Orthopaedica 2010; 81 (1): 34–41
In contrast, after adjustment for sex, age, and underlying 
diagnosis, uncemented stem components had a lower risk of 
stem revision due to aseptic loosening than cemented stems 
(RR = 0.4, CI: 0.3–0.5) (Table 6).
Revision risk within 2 years of the index procedure
A Cox regression model with revision within 2 years of the 
index procedure (of any component and for any reason) as the 
endpoint showed that uncemented arthroplasties had a higher 
risk of revision than cemented arthroplasties during this early 
time period (RR = 1.8, CI: 1.5–2.2). The reasons for revision 
within 2 years differed markedly between the two groups. The 
main finding was that a much higher proportion of uncemented 
THAs were revised due to periprosthetic fracture during the first 
2 years, 17% in the group of uncemented THAs versus 6% in 
the group of cemented THAs. Cox regression analysis adjusting 
for sex, age, and underlying diagnosis showed that the risk of 
stem revision due to periprosthetic fracture within 2 years of the 
index procedure was remarkably high when comparing unce-
mented and cemented THAs (RR = 8, CI: 5–14) (Table 6).
Revision risk of commonly used cups and stems
The risk of revision for various reasons was also calculated 
after selection of THAs where the 5 most commonly used 
implants  in  each  group  had  been  used.  It  became  appar-
ent that the risk of cup revision for any reason was similar 
between the 5 most commonly used cemented cups and the 5 
most commonly used uncemented cups (RR for uncemented 
vs. cemented cups = 0.9, CI: 0.6–1.1). With cup revision due 
to aseptic loosening as the endpoint, the risk of revision was 
lower in the group of 5 most commonly used uncemented cups 
compared with the group of 5 most commonly used cemented 
cups (RR = 0.5, CI: 0.3–0.8) (Table 6). The mean observation 
time was 3.2 years (SD 3) for the group of 5 most common 
uncemented cups and 5.8 years (SD 4) for the group of 5 most 
common cemented cups.
The risk of stem revision for any reason was lower for the 5 
most commonly used uncemented stems than for the 5 most 
commonly used cemented stems (RR = 0.5, CI: 0.4–0.6) (Table 
6). With the risk of stem revision due to aseptic loosening as 
the endpoint of the analysis, it was found that the 5 most com-
monly used uncemented stems again had a lower risk of revi-
sion than the 5 most commonly used cemented stems (RR = 
0.3, CI: 0.2–0.4; Table 6). The mean observation time was 5.1 
years (SD 4.3) for the group of 5 most common uncemented 
stems and 5.8 years (SD 4) for the group of 5 most common 
cemented stems.
Because the design of non-cemented hip arthroplasty com-
ponents has been altered since the introduction of uncemented 
fixation, and because surgical experience with uncemented 
implants has increased over time, we thought it possible that 
contemporary uncemented THA would show improved com-
ponent survival compared to older devices and compared to 
devices implanted early after the introduction of uncemented 
THA in Sweden. We therefore performed the same analyses 
as described above, but restricted data selection to all hips that 
were operated from the year 2000 onward. The risk of revision 
of any component for any reason was still higher for unce-
mented THA than for cemented THA (RR = 1.5, CI: 1.2–1.8) 
(Table 6).
Discussion
The Swedish experience of inferior results with uncemented 
THA contrasts with the general conception of this type of 
fixation (Morshed et al. 2007). Nonetheless, the use of unce-
mented fixation is increasing even in Sweden, for unknown 
reasons. Factors such as shorter operation time, good docu-
mentation of some uncemented designs in the SHAR and the 
Norwegian arthroplasty register, and large cohort studies may 
have stimulated this development.
Table 6. Summary of adjusted risk ratios. Revision during the entire study period
Endpoint   Population investigated   Reference population   Adjusted RR (CI)   p-value
Revision of any component 
  for any reason  All uncemented implants  All cemented implants  1.5 (1.4–1.6)  < 0.001
  due to aseptic loosening  All uncemented implants  All cemented implants  1.5 (1.3–1.6)  < 0.001
  due to deep infection   All uncemented implants  All cemented implants  0.9 (0.6–1.3)  0.5
  for any reason  All uncemented implants from 2000  All cemented implants from 2000  1.5 (1.2–1.8)  < 0.001
Cup revision due to aseptic loosening  All uncemented cups  All cemented cups  1.8 (1.6–2.0)  < 0.001
Stem revision due to aseptic loosening  All uncemented stems  All cemented stems  0.4 (0.3–0.5)  < 0.001
Revision for any reason within 2 years 
  of the index procedure  All uncemented implants  All cemented implants  1.8 (1.5–2.2)  < 0.001
Stem revision due to fracture within 
  2 years of the index procedure  All uncemented stems  All cemented stems  8.0 (4.5–14)  < 0.001
Cup revision for any reason  5 most common uncemented cups  5 most common cemented cups  0.9 (0.6–1.1)  0.2
Cup revision due to aseptic loosening  5 most common uncemented cups  5 most common cemented cups  0.5 (0.3–0.8)  0.001
Stem revision for any reason  5 most common uncemented stems  5 most common cemented stems  0.5 (0.4–0.6)  < 0.001
Stem revision due to aseptic loosening  5 most common uncemented stems  5 most common cemented stems  0.3 (0.2–0.4)  < 0.001Acta Orthopaedica 2010; 81 (1): 34–41  39
We found that no age group or diagnosis group benefited 
from the choice of uncemented THA, which conflicts with 
findings on the superior outcome of uncemented arthroplasty 
in younger groups of patients (Eskelinen et al. 2006, Hooper 
et al. 2009). This is also contrasted by research on the biol-
ogy of osseointegration of uncemented implants, where the 
potential of implant integration into host bone has been used 
as an argument for uncemented fixation (Willert and Buch-
horn 1999). On the basis of our findings, there is nothing to 
support the notion that younger patients with a diagnosis of 
primary osteoarthritis can expect better revision-free survival 
after uncemented fixation than after cemented fixation.
Separate analyses of the cup and stem components revealed 
that they contributed to the risk of revision in different ways. 
In uncemented THA, the acetabular cup appeared to be the 
component that was associated with increased risk of revision, 
irrespective of whether revision for any reason or due to asep-
tic loosening was considered. In contrast, uncemented stems 
performed better than cemented stems, again irrespective of 
the chosen endpoint of analysis.
The  observation  that  uncemented  fixation  of  metal  cups 
provides inferior long-term results could be attributed to an 
increased risk of wear-related problems. Because the risk of 
revision persisted after exclusion of isolated liner exchanges 
in our analyses, it seems reasonable to believe that osteolysis 
and wearing-through of the liner, with secondary damage to 
the shell, were important reasons for revision. Several studies 
have indicated that an isolated liner exchange increases the risk 
of further revisions, and not least increases the risk of disloca-
tion (Lie et al. 2007). This may have stimulated a more active 
attitude among Swedish surgeons to also extract the shell in 
situations of revision due to liner wear. However, according to 
numerous studies, migration and loosening of modern press-
fit cup designs is rare (Thanner et al. 2000, Rohrl et al. 2006). 
In the SHAR, loosening, wear, and osteolysis are not primar-
ily separated as causes of revision.
The question of whether the superior long-term results of 
some  monobloc  cup  designs,  where  the  polyethylene  has 
been molded into various metal cases are superior, cannot be 
answered in this study, because none of these cups has been 
in frequent use in Sweden. As for many other contemporary 
designs  and  articulations,  mostly  medium-term  results  are 
available for monobloc cups (Hinrichs et al. 2001, Unger et 
al.  2005,  Malizos  et  al.  2008,  Gwynne-Jones  et  al.  2009). 
However, problems due to osteolysis and wear rarely result in 
revision surgery until 6–8 years have elapsed; thus, optimistic 
reports on the survival of monobloc cups must be regarded 
with some caution. 
Detailed information on the type of polyethylene was not 
available for our analysis; therefore, inferior performance of 
certain types of polyethylene that were predominantly used 
in uncemented cups may have influenced our findings, but we 
do not believe that this accounts for the overall inferior per-
formance of uncemented cups. Alternative bearing types such 
as  metal-on-metal,  ceramic-on-polyethylene,  and  ceramic-
on-ceramic have not been in widespread use in Sweden; thus, 
various problems associated with these bearing types should 
not have distorted our findings.
In contrast to the inferior performance of uncemented cups, 
we found superior survival of uncemented stems compared to 
cemented stems. This finding could at least in part be explained 
by the fact that cemented stems of smaller sizes, i.e. mostly 
stems inserted into narrow femora, have an increased risk of 
revision, perhaps due to thin or absent cement mantles (Swed-
ish National Hip Arthroplasty Register, Annual Report 2005). 
We also found that the risk of early revision due to fracture was 
much higher for uncemented stems than for cemented stems. It 
could be proposed that this finding indicates that patients who 
receive uncemented arthroplasty are more vulnerable to trauma 
during the first postoperative year, although the fact that the 
risk ratio has been adjusted for age, sex, and underlying diag-
nosis in the Cox regression model contradicts this proposal. 
It  seems  more  probable  that  some  of  these  fractures  occur 
during the index operation but remain undetected at the time of 
surgery. In some cases, minor fissures—invisible on ordinary 
radiographs—may have been produced during stem insertion, 
which may explain why these patients suffer a manifest peri-
prosthetic fracture even after minor trauma. This hypothesis is 
supported by reports of a relatively high incidence of intraop-
erative fractures associated with stem insertion during unce-
mented THA (Fernandez-Fernandez et al. 2008).
The issue of periprosthetic fractures is probably related to 
general surgical experience, and to implant-specific learning 
curves. It could be argued that cemented arthroplasty is a more 
forgiving technique than uncemented arthroplasty, although 
the finding of high revision rates after improperly performed 
cementation indicates that cemented THA has its own pitfalls. 
The SHAR has not been designed to investigate single-sur-
geon outcomes; the aspect of learning curves cannot therefore 
be analyzed in detail. It does, however, seem reasonable to 
assume that theoretical and practical education of surgeons 
who are introduced to uncemented THA should be able to 
reduce the risk of complications mentioned above.
It has been proposed that hip arthroplasties fixed with anti-
biotic-laden cement should be less prone to deep infection 
than cemented implants fixed with conventional cement that 
contains no additional antibiotics (Engesaeter et al. 2003, Par-
vizi et al. 2008). In the SHAR, more than 90% of the cases 
were cemented with antibiotic-laden cement, but further anal-
ysis of this factor is uncertain because the use of cement has 
often been reported with data aggregated for each participat-
ing unit. Regarding the risk of deep infection, to our knowl-
edge no other direct comparison of large groups of patients 
receiving  either  cemented  or  uncemented  arthroplasty  has 
been published. Thus, it appears that the risk of revision due 
to infection should be about equal if uncemented fixation is 
compared with cemented fixation, provided that the cement is 
antibiotic-laden.40  Acta Orthopaedica 2010; 81 (1): 34–41
In a separate analysis, we investigated the risk of revision 
of commonly used uncemented or cemented cup and stem 
designs. We found that the most commonly used uncemented 
cups did not show any increased risk of revision for any reason 
when  compared  with  the  most  commonly  used  cemented 
cups. When revision due to aseptic loosening was considered, 
common uncemented cups even seemed to perform better than 
common cemented cups. On the other hand, the mean time 
of observation of uncemented cups was shorter than that of 
cemented cups; thus, future problems of wear and osteolysis 
could distort this finding. When commonly used uncemented 
stems were compared with commonly used cemented stems, 
the  previously  described  advantage  of  uncemented  stems 
observed in the entire study cohort was confirmed: the group 
of commonly used uncemented stems had a lower risk of revi-
sion for any reason and a lower risk of revision due to aseptic 
loosening than commonly used cemented stems. We therefore 
believe  that  our  analysis  is  not  unfavorably  biased  against 
uncemented THA itself, but that our findings highlight that at 
least some of the difficulties associated with early uncemented 
implant  fixation  have  been  recognized  and  reduced  in  the 
uncemented designs that now prevail on the Swedish market.
Several weaknesses must be kept in mind during the inter-
pretation of our data: (1) all registry studies suffer from spe-
cific uncertainties concerning data collection, reliability, and 
validity, and this also applies to the present material. How-
ever, in the light of previously performed validations of the 
SHAR, we believe that the error margins are small and do not 
substantially distort the basic findings of our study (Söderman 
2000); (2) a further potential weakness is the large variation in 
the choice of implants. Variations in the type of implant were 
larger among uncemented components than among cemented 
components: the 10 most common cemented cups and stems 
made up more than 90% of all implants, whereas the 10 most 
common uncemented implants only covered 80% of all com-
ponents. Thus, the group of uncemented THAs was more het-
erogeneous, and a number of uncemented designs with infe-
rior performance—although not very widely used or even out 
of current use—could distort the performance of the group of 
uncemented THAs as a whole. However, some implants with 
known catastrophic results, such as the ABG I cup, were not in 
widespread use in Sweden during the study period and should 
therefore not have negatively biased the group of uncemented 
cups as a whole (Blacha 2004). It remains to be seen whether 
future use of designs with superior survival will improve the 
general performance of uncemented THAs.
A registry study such as ours cannot be compared directly 
with the results of a defined implant in the hands of a dedi-
cated, often small group of surgeons—such as in most small 
or medium-sized cohort studies. Our study rather reflects the 
nationwide outcome of many different implants in many dif-
ferent hands, with surgeons who are more or less experienced 
in the technique of uncemented THA surgery. It would there-
fore be over-hasty to condemn uncemented THA as a whole, 
but a few words of caution should suffice: (1) uncemented cups 
are the Achilles’ tendon of uncemented THA. It remains to be 
seen whether other types of cup or liner fixation, cup coat-
ing, or more wear-resistant surface bearings can reduce the 
problem of cup loosening; (2) the risk of stem revision due to 
fracture during the first 2 years is approximately 8-fold higher 
for uncemented stems than for cemented stems. This indicates 
that  a  number  of  perioperatively  induced  femoral  fissures 
remain unrecognized, which is probably a question of surgical 
technique. The need for proper training of surgeons who start 
using uncemented implants is highlighted by these findings. 
Our study does not support the notion that uncemented THA is 
superior to cemented THA when looking at long-term implant 
survival. At best, some of the common contemporary designs 
can reach an outcome that equals that of cemented THA.
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